04/11/2024
8:44 AM | Harmony Biosciences (Filer)
| Form ARS | |
04/11/2024
7:30 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
7:17 AM | Harmony Biosciences (Filer)
| Form DEF 14A | |
04/11/2024
7:18 AM | Harmony Biosciences (Filer)
| Form DEFA14A | |
03/18/2024
6:24 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:24 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
4:17 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/08/2024
3:21 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
4:16 PM | Harmony Biosciences (Filer)
| Form 10-K/A | |
02/22/2024
7:00 AM | Harmony Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/22/2024
6:45 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
6:06 PM | Harmony Biosciences (Subject)
Valor IV Pharma Holdings, LLC (Filed by)
| Form SC 13G/A | |
01/24/2024
1:27 PM | BlackRock Inc. (Filed by)
Harmony Biosciences (Subject)
| Form SC 13G/A | |
01/08/2024
7:30 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2023
7:59 AM | Anastasiou Peter (Reporting)
Harmony Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/08/2023
8:03 AM | Anastasiou Peter (Reporting)
Harmony Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
7:30 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2023
7:00 AM | Harmony Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2023
6:45 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/13/2023
7:15 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2023
7:31 AM | Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
| Form SC TO-T/A | |
10/11/2023
7:15 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/06/2023
1:34 PM | BlackRock Inc. (Filed by)
Harmony Biosciences (Subject)
| Form SC 13G/A | |
10/05/2023
3:15 PM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/05/2023
3:15 PM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
7:00 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2023
7:12 AM | Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
| Form SC TO-T/A | |
09/25/2023
7:00 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/14/2023
3:59 PM | Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
| Form SC TO-T/A | |
09/14/2023
3:42 PM | Harmony Biosciences (Filer)
| Form 8-K/A | |
08/28/2023
7:23 AM | Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
| Form SC TO-T | |
08/24/2023
4:23 PM | Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
| Form SC 13D | |
08/14/2023
4:26 PM | Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
| Form SC TO-C | |
08/14/2023
4:27 PM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
4:29 PM | Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
| Form SC TO-C | |
08/01/2023
7:01 AM | Harmony Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2023
6:45 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/27/2023
7:30 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2023
3:37 PM | Dayno Jeffrey M. (Reporting)
Harmony Biosciences (Issuer)
| Form 4/A | |
05/26/2023
4:25 PM | Harmony Biosciences (Issuer)
Nielsen Jack (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
3:20 PM | Gracias Antonio J. (Reporting)
Harmony Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad) “Titan of Tech” Bets Big on Tiny AI Company
He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal…
But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him |
05/26/2023
3:26 PM | Harmony Biosciences (Issuer)
Sabater Juan A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
7:00 AM | Harmony Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2023
7:20 AM | Harmony Biosciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/02/2023
6:45 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
